NAALADL1 modulates cellular resistance to Tumor Treating Fields in colorectal cancer
Zhaoran Su, Menglan Liu, Mathias Krohn, Jasmin Ostermann, Sandra Schwarz, Olga Hahn, Marcus Frank, Timo Gemoll, Clemens Schafmayer, Michael Linnebacher · 2026
Read NAALADL1 modulates cellular resistance to Tumor Treating Fields in colorectal cancer by Zhaoran Su, Menglan Liu, Mathias Krohn, Jasmin Ostermann, Sandra Schwarz, Olga Hahn, Marcus Frank, Timo Gemoll, Clemens Schafmayer, Michael Linnebacher (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13213047.txt.
Description
Zhaoran Su and a large team investigate in 2026 why some colorectal cancer cells resist a therapy that uses alternating electric fields to wreck cell division. The treatment, already used for a brain cancer, had never been tested systematically across many bowel cancer cell lines.
Across a broad panel of patient-derived lines, the fields damaged cells through several routes, from scrambled division machinery to DNA damage and cell death. One gene stood out as switched on in resistant lines. Silencing it made cells sensitive again, and computer screening nominated two existing drugs that might block its product and boost the therapy. The gene could become a target for combination treatment.
Catalog record
| CREATOR | Zhaoran Su, Menglan Liu, Mathias Krohn, Jasmin Ostermann, Sandra Schwarz, Olga Hahn, Marcus Frank, Timo Gemoll, Clemens Schafmayer, Michael Linnebacher |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |